Report - TABLE OF CONTENTS - accessdata.fda.gov · AstraZeneca Pharmaceuticals LP has submitted this supplemental new drug application (sNDA) 21929/S-013, for SYMBICORT® (budesonide/formoterol)

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form